| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A DNA vaccine expressing an optimized secreted FAPα induces enhanced anti-tumor activity by altering the tumor microenvironment in a murine model of breast cancer
|
Geng, Fei
|
|
2019
|
37 |
31 |
p. 4382-4391
|
article
|
| 2 |
A multi-epitope DNA vaccine co-administered with monophosphoryl lipid A adjuvant provides protection against tick transmitted Ehrlichia ruminantium in sheep
|
Tshilwane, S.I.
|
|
2019
|
37 |
31 |
p. 4354-4363
|
article
|
| 3 |
An amphiphilic invertible polymer as a delivery vehicle for a M2e-HA2-HA1 peptide vaccine against an Influenza A virus in pigs
|
Singh, Gagandeep
|
|
2019
|
37 |
31 |
p. 4291-4301
|
article
|
| 4 |
An evolution in thinking to support the post 2020 global vaccine strategy: The application of complexity and implementation science
|
Dowell, Anthony C.
|
|
2019
|
37 |
31 |
p. 4236-4240
|
article
|
| 5 |
An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages
|
Tambyah, Paul A.
|
|
2019
|
37 |
31 |
p. 4344-4353
|
article
|
| 6 |
An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines
|
Hauser, Michael I.
|
|
2019
|
37 |
31 |
p. 4246-4255
|
article
|
| 7 |
An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool
|
Bellan, Steven E.
|
|
2019
|
37 |
31 |
p. 4376-4381
|
article
|
| 8 |
Anthropometric, cognitive, and schooling benefits of measles vaccination: Longitudinal cohort analysis in Ethiopia, India, and Vietnam
|
Nandi, Arindam
|
|
2019
|
37 |
31 |
p. 4336-4343
|
article
|
| 9 |
A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model
|
Hewitt, Joshua S.
|
|
2019
|
37 |
31 |
p. 4302-4309
|
article
|
| 10 |
A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants
|
Ella, Raches
|
|
2019
|
37 |
31 |
p. 4407-4413
|
article
|
| 11 |
Bolstering trust in the human papillomavirus vaccine through improved communication in the vaccine information statement
|
Constable, Catherine
|
|
2019
|
37 |
31 |
p. 4241-4242
|
article
|
| 12 |
Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort
|
Kwong, Jeffrey C.
|
|
2019
|
37 |
31 |
p. 4392-4400
|
article
|
| 13 |
Economic and immunisation safety surveillance characteristics of countries implementing no-fault compensation programmes for vaccine injuries
|
Mungwira, Randy G.
|
|
2019
|
37 |
31 |
p. 4370-4375
|
article
|
| 14 |
Editorial Board/Aims and Scope
|
|
|
2019
|
37 |
31 |
p. IFC
|
article
|
| 15 |
Effectiveness of the herpes zoster vaccine Zostavax® in Stockholm County, Sweden
|
Blom, Kim
|
|
2019
|
37 |
31 |
p. 4401-4406
|
article
|
| 16 |
Immunization with a peptide mimicking Lipoteichoic acid protects mice against Staphylococcus aureus infection
|
Yi, Xia-Yu
|
|
2019
|
37 |
31 |
p. 4325-4335
|
article
|
| 17 |
Impact of a mass vaccination campaign against Serogroup B meningococcal disease in the Saguenay-Lac-Saint-Jean region of Quebec four years after its launch
|
Deceuninck, G.
|
|
2019
|
37 |
31 |
p. 4243-4245
|
article
|
| 18 |
Influenza immunisation coverage from 2015 to 2017: A national study of adult patients from Australian general practice
|
De Oliveira Bernardo, Carla
|
|
2019
|
37 |
31 |
p. 4268-4274
|
article
|
| 19 |
Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection
|
Renson, Patricia
|
|
2019
|
37 |
31 |
p. 4318-4324
|
article
|
| 20 |
Missed Opportunities for HPV Vaccination Among Vaccine-Eligible Women with High Grade Cervical Lesions
|
Russ, Savanah M.
|
|
2019
|
37 |
31 |
p. 4262-4267
|
article
|
| 21 |
ONRAB® oral rabies vaccine is shed from, but does not persist in, captive mammals
|
Sobey, Kirk G.
|
|
2019
|
37 |
31 |
p. 4310-4317
|
article
|
| 22 |
Opportunities to improve vaccination coverage in a country with a fledgling health system: Findings from an assessment of missed opportunities for vaccination among health center attendees—Timor Leste, 2016
|
Li, Anyie J.
|
|
2019
|
37 |
31 |
p. 4281-4290
|
article
|
| 23 |
Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses
|
Song, Shasha
|
|
2019
|
37 |
31 |
p. 4364-4369
|
article
|
| 24 |
Physician clinical decision support system prompts and administration of subsequent doses of HPV vaccine: A randomized clinical trial
|
Wilkinson, Tracey A.
|
|
2019
|
37 |
31 |
p. 4414-4418
|
article
|
| 25 |
Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study
|
Zaman, Khalequ
|
|
2019
|
37 |
31 |
p. 4275-4280
|
article
|
| 26 |
1st WHO International Standard antiserum to RSV: Availability and benefits for RSV vaccine development (Commentary on the collaborative study report published in the vaccine journal (Vaccine 2018 36: 7641–7649))
|
Knezevic, Ivana
|
|
2019
|
37 |
31 |
p. 4233-4235
|
article
|
| 27 |
Use of controlled human infection models (CHIMs) to support vaccine development: US regulatory considerations
|
Ramanathan, Roshan
|
|
2019
|
37 |
31 |
p. 4256-4261
|
article
|
Journal description